Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06275919
Title Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial) (MIRAGE)
Acronym MIRAGE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Istituto Oncologico Veneto IRCCS
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA

Facility Status City State Zip Country Details
IRST Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" RECRUITING Meldola Forlì-Cesena Italy Details
Azienda Ospedaliera Universitaria Gaetano Martino NOT_YET_RECRUITING Messina Italia/Messina 98124 Italy Details
Humanitas Cancer Center NOT_YET_RECRUITING Rozzano Milano Italy Details
Ospedale San Paolo RECRUITING Bari Italy Details
Ospedale Bellaria - AUSL Bologna RECRUITING Bologna Italy Details
Azienda Ospedaliero Universitaria Careggi NOT_YET_RECRUITING Firenze Italy Details
Policlinico San Martino NOT_YET_RECRUITING Genova Italy Details
Spedali Riuniti RECRUITING Livorno Italy Details
Fondazione IRCCS Istituto Neurologico Carlo Besta RECRUITING Milano Italy Details
IRCCS Ospedale San Raffaele NOT_YET_RECRUITING Milano Italy Details
Ospedale del Mare NOT_YET_RECRUITING Napoli Italy Details
Istituto Oncologico Veneto RECRUITING Padova 35128 Italy Details
Fondazione Policlinico Universitario Agostino Gemelli IRCCS NOT_YET_RECRUITING Roma Italy Details
IRCCS Istituto Tumori Regina Elena NOT_YET_RECRUITING Roma Italy Details
Policlinico Umberto I - Università Sapienza Roma NOT_YET_RECRUITING Roma Italy Details
A.O.U. Città della Salute e della Scienza di Torino NOT_YET_RECRUITING Torino Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field